Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025, for Kestrel Group Ltd (NASDAQ: KG). The reporting period is significantly impacted by the completion of a business combination on May 27, 2025, between Kestrel Group LLC and Maiden Holdings, Ltd. The transaction was accounted for as a reverse acquisition, with Kestrel LLC treated as the accounting acquirer. The Company operates two primary segments: Program Services (fee-based fronting services) and Legacy Reinsurance (run-off of Maiden's reinsurance portfolios).
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2025 | Nine Months Ended Sept 30, 2025 |
|---|---|---|
| Net Income (Loss) | $(5.1) million | $64.5 million |
| EPS (Basic & Diluted) | $(0.65) | $12.70 |
| Total Revenues | $17.4 million | $23.8 million |
| Net Premiums Earned | $6.8 million | $9.3 million |
| Fee Revenue | $1.6 million | $3.0 million |
| Net Investment Income | $3.5 million | $5.1 million |
| Net Realized/Unrealized Investment Gains | $5.5 million | $6.6 million |
| Total Assets | $1.13 billion | (N/A - Balance Sheet Item) |
| Total Liabilities | $986.7 million | (N/A - Balance Sheet Item) |
| Shareholders' Equity | $143.8 million | (N/A - Balance Sheet Item) |
| Senior Notes (Principal) | $262.4 million | (N/A - Balance Sheet Item) |
| Cash & Cash Equivalents (Total) | $40.5 million | (N/A - Balance Sheet Item) |
Note: Nine-month net income includes a non-recurring bargain purchase gain of $73.6 million.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased from $0.8 million (3-month 2024) to $17.4 million (3-month 2025) and from $2.6 million (9-month 2024) to $23.8 million (9-month 2025), driven by the inclusion of Maiden's operations post-combination.
- Profitability: The Company reported a net loss of $5.1 million for the quarter, compared to a loss of $0.4 million in the prior year quarter. However, the nine-month period showed a net income of $64.5 million versus a loss of $1.4 million in the prior year, primarily due to the $73.6 million bargain purchase gain.
- Underwriting Results: The Legacy Reinsurance segment reported an underwriting loss of $9.0 million for the quarter, driven by adverse prior year loss development (PPD) of $6.6 million, largely attributed to the European Hospital Liability Quota Share. The Program Services segment generated fee income of $1.0 million.
- Balance Sheet Expansion: Total assets grew from $5.5 million at December 31, 2024, to $1.13 billion at September 30, 2025, reflecting the acquisition of Maiden's investment portfolio and reinsurance assets.
Guidance, Outlook, and Risks
- Strategic Focus: Management intends to grow the fee-based Program Services segment while running off the Legacy Reinsurance portfolios. The Company plans to dispose of alternative investments to improve liquidity and reposition the balance sheet.
- Capital Resources: The Company holds $40.5 million in cash and restricted cash. It has $33.4 million in unfunded commitments for alternative investments but has ceased making new commitments. Maiden Reinsurance paid $40.0 million in dividends to shareholders at closing and $21.3 million under an annual dividend program during the nine-month period.
- Legal Proceedings:
- Securities Class Action: A putative class action regarding alleged inadequate loss reserves was remanded to the District Court by the Third Circuit Court of Appeals in August 2025, allowing plaintiffs to pursue discovery.
- Senior Notes Litigation: Holders of the 2013 Senior Notes filed a lawsuit alleging a breach of indenture regarding a prior asset sale. The District Court granted a motion to dismiss in June 2025, but plaintiffs have appealed and filed a new complaint in August 2025.
- Internal Controls: The Company disclosed a material weakness in internal control over financial reporting related to Kestrel Group LLC's revenue recognition and IT controls, which existed prior to the combination and had not been fully remediated as of September 30, 2025.
- Foreign Exchange: The Company has significant exposure to the Euro and British Pound. Net foreign exchange gains of $2.9 million were recorded in the quarter due to USD appreciation, while the nine-month period saw a loss of $2.2 million due to USD depreciation.
Investor Verification Checklist
- Bargain Purchase Gain: Verify the sustainability of the $73.6 million gain recognized in the nine-month period, as it is a non-recurring item resulting from the acquisition accounting.
- Legacy Reserve Adequacy: Review the adverse prior year loss development ($6.6 million in Q3) in the AmTrust Legacy Reinsurance segment, specifically regarding the European Hospital Liability Quota Share.
- Liquidity vs. Collateral: Assess the impact of restricted assets ($211.6 million in restricted cash and investments) on available liquidity for operations and debt service.
- Internal Control Remediation: Monitor the progress of remediation efforts for the disclosed material weakness in internal controls over financial reporting.
- Legal Exposure: Track the status of the remanded securities class action and the appeal regarding the 2013 Senior Notes litigation.
- Alternative Investment Disposal: Evaluate the timeline and potential valuation impact of the Company's plan to dispose of its $215.7 million alternative investment portfolio.